哈密包茎手术多少钱哈密女人避孕环多久换一次,哈密早期怀孕多少天能查出来,哈密哪个医院宫颈息肉好,哈密男科哪家的好,哈密做一次男科检查大概多少钱,哈密包皮手术哪个医院,哈密早早孕两条线

CHENGDU, Sept. 20 (Xinhua) -- A United Nations official said Tuesday that she hopes China will take every opportunity to reinforce, support and lead the UN's agenda and "infuse it with strength and wisdom.""The more China gives, the better the UN can become," said Renata Lok-Dessallien, UN Resident Coordinator and United Nations Development Program (UNDP) Resident Representative in China, at the Seminar in Memory of the 40th Anniversary of the Resumption of Lawful Rights of China in the United Nations.The three-day seminar from Sept. 19 to 21 is being held in the city of Chengdu in southwest China's Sichuan Province. About 100 UN and Chinese officials are gathering to discuss China's role in the UN, as well as the UN's role in global diplomacy.Lok-Dessallien said that the General Assembly Resolution of Oct. 25, 1971 was an "important milestone in China's international relations and in the history of the United Nations.""It restored the rights of the People's Republic of China in the United Nations and marked China's entry to the world stage," she said.Steven Sabey, a senior policy advisor from the UNDP's China office, said that China plays an important role in facilitating cooperation about the member states of the United Nations."China needs the United Nations, and the United Nations also needs China," said Wu Hailong, China's assistant minister of foreign affairs."We must recognize that as the largest developing country in the world, China needs to manage its domestic affairs first, as this can have a positive effect on humanity as a whole," Wu said.As China's role in the world continues to grow and evolve, the UN's role in China will also grow, according to Lok-Dessallien."As China's development trajectory continues to evolve, we are entering significantly new territory in the UN-China relationship," she said.Sabey said that he hopes China will strengthen its cooperation with the United Nations in order to further improve intercultural communication and allow China to contribute more to other developing countries."The United Nations is committed to continuing to deepen and strengthen our partnership as we tackle the many global challenges ahead," said Lok-Dessallien.

LOS ANGELES, July 19 (Xinhua) -- Obesity prevalence was 30 percent or higher in 12 states of the United States last year, compared to nine states in 2009, the Centers for Disease Control and Prevention (CDC) said on Tuesday.In 2000, no states in the country had obesity rates that high, and now obesity is a problem in all 50 states, the agency said in a report based on telephone interviews with 400,000 people.Obesity rates vary by region, led by the South at 29.4 percent, followed by the Midwest at 28.7 percent, the Northeast at 24.9 percent, and the West at 24.1 percent, the report said.Mississippi had the nation's highest obesity prevalence at 34 percent, and Colorado the lowest at 21 percent, according to the report.Alabama, Arkansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Oklahoma, South Carolina, Tennessee, Texas, and West Virginia all had obesity rates of 30 percent or higher in 2010, said the report.No state met the federal Healthy People 2010 goal of a 15 percent obesity rate. In fact, no state had a rate lower than 20 percent, the CDC said.Obesity rates have kept rising despite a steady drumbeat of warnings that obesity causes serious health problems and increases the risk of premature death, CDC officials said.An adult is considered obese if he or she has a body mass index (BMI) of 30 or greater.

LOS ANGELES, June 5 (Xinhua) -- U.S. researchers have developed two new drugs that can prolong the lives of patients with advanced melanoma, it was announced on Sunday.Research on both drugs was presented at the on-going annual meeting of the American Society of Clinical Oncology in Chicago, according to HealthDay News.This is the first big news in years for treatment of melanoma, one of the deadliest forms of skin cancer and one that is notoriously difficult to treat, let alone cure, the report said.The first treatment, vemurafenib, inhibits a gene mutation harbored in half of all melanoma patients, but is not yet approved by the U.S. Food and Drug Administration.The other drug, Yervoy (ipilumumab), is an immune system therapy that won approval in March."The March FDA approval of ipilumumab (Yervoy) was the first new drug approval for melanoma in 13 years," said Tim Turnham, executive director of the Melanoma Research Foundation.The two drugs were developed by researchers at Memorial Sloan- Kettering Cancer Center in New York City, the report said."This is really a huge step toward personalized care in melanoma," Dr. Paul Chapman, lead author of the first study and the attending physician in the melanoma/sarcoma service at Memorial Sloan-Kettering, said in a statement. "This (vemurafenib) is the first successful melanoma treatment tailored to patients who carry a specific gene mutation in their tumor, and could eventually become one of only two drugs available that improves overall survival in advanced cancers.""Having two trials that show a benefit in survival in patients with melanoma, both of these in first-line settings -- we weren't here just a few years ago," said Dr. Stephen Hodi, director of the Melanoma Center at Dana Farber Cancer Institute in Boston. "These are huge, paradigm-shifting results for the field."In the vemurafenib trial, sponsored by the drug's makers, researchers randomly assigned 675 patients with advanced, inoperable melanoma to receive either the chemotherapy drug dacarbazine or vemurafenib. Vemurafenib targets the V600E mutation in the BRAF gene.At the three-month mark, patients taking vemurafenib were 63 percent less likely to die and 74 percent less likely to die or see their cancer return, compared to patients taking dacarbazine alone.Few patients had side effects in the vemurafenib group, although some did develop squamous cell carcinoma, a less dangerous form of skin cancer.This is the first drug that has been proven superior to chemotherapy in this group of hard-to-treat patients, the researchers said."There was such a substantial benefit that we recommended that patients cross over," Chapman said at a Sunday news briefing. "It' s unprecedented to report a trial this early. The median follow-up time was three months." Yet the differences between the two groups became evident almost immediately.Dr. Lynn Schuchter, co-moderator of the briefing and division chief of hematology-oncology at Abramson Cancer Center of the University of Pennsylvania in Philadelphia, said symptoms subsided in some patients almost immediately, enabling them to cut back on pain medication in just 72 hours."The median time to progression with dacarbazine was 1.6 months versus three months with vemurafenib, which is a huge difference," said Chapman.In the second study, about 500 patients were randomly picked to receive Yervoy plus dacarbazine or dacarbazine alone.Those taking both drugs lived a median of 11.2 months compared to 9.1 months for those taking dacarbazine alone. Time to recurrence of disease was about the same for both groups: 2.8 months and 2.6 months, respectively.Almost half of those taking the combination therapy were alive after one year, compared to 36.3 percent in the other group. After two years, the rates were 28.5 percent and 17.9 percent, respectively.By three years out, 20.8 percent of those in the combination group were alive compared with 12.2 percent of those taking chemotherapy alone.This is the first study to combine chemotherapy and immunotherapy both safely and effectively.A study to test vemurafenib in combination with Yervoy has already begun, according to HealthDay News.

PARIS, June 19 (Xinhua) -- Commercial Aircraft Corporation of China Ltd. (Comac) on Sunday set up its European office in Paris, the second overseas branch after its U.S. office, marking a new step for China's aviation industry in opening-up and international exchanges."The establishment of Comac Europe office is very significant. It represents the strategic cooperation between China and France and will deepen the two sides' collaboration in aerospace and all areas concerned," Chinese Ambassador Kong Quan said at an opening ceremony, citing Europe's influence in global aerospace industry and civil aviation market."Taking self-dependent innovation as the strategic cornerstone, Comac meanwhile actively conducts international cooperation and draws upon advanced technologies and experience in global civil aviation industry...," Comac President Jin Zhuanglong said.French Secretary of State for Transport Thierry Mariani (4th L), Chinese Ambassador to France Kong Quan (3rd L) and General Manager of the Commercial Aircraft Corporation of China (COMAC) Jin Zhuanglong (2nd R) attend the unveiling ceremony of COMAC Europe Office in Paris, France, June 19, 2011. The COMAC Europe Office was offically opened here Sunday.The Chinese aerospace manufacturer has built up cooperative relationship and partnership with dozens of enterprises and institutions in many countries and regions since its establishment in May 2008 in Shanghai.Regional jet ARJ21 and the trunkliner C919 are two flagship products of the young Chinese company. The group is now working to achieve certification and delivery of ARJ21-700 aircraft by the end of this year, Jin said.With regard to China's C919 trunkliner program, Jin said COMAC has signed cooperation agreements with 17 international companies in the United States and Europe, and has actively explored collaboration with GECAS, British Airways and Ryanair."In the context that the world economy is on recovery from the financial crisis, the civil aviation industry is facing great challenge. We are willing to keep close contact with all relevant public administrations and forge friendly relations and cooperation with overseas suppliers to contribute to the development of world civil aviation industry," Jin said.For the French State Secretary for Transport Thierry Marianne, who also attended the opening ceremony, the Chinese aviation market has great potential in the years to come, and China is estimated to need 3,000 new planes."We have understood that China had decided to build its own aerospace industry. It is a legitimate choice," Marianne said.A demo mock-up of the full-scale forward fuselage of C919 will be displayed during the 49th Paris Air Show on June 20-26, which will be the first time that the 1:1 demo mock-up is to be showcased at an international stage outside China, Jin told Xinhua.During the air show, Comac is going to sign agreements with an international airline and an airborne-system supplier and carry out a series of activities concerning international cooperation and exchanges, according to the group.

KATSINA, Nigeria May 31 (Xinhua) -- At least 10 secondary school teachers are reported to have died of food poisoning, and several others hospitalized in northern Nigeria's Katsina State, the News Agency of Nigeria reported on Tuesday.The incident occurred at the weekend at a workshop organiZed by the state Ministry of Education for some 650 teachers at Government Day Secondary School (GDSS), Kofar Yan'daka, Katsina.The report said soon after taking their lunch, supplied by a popular corporate caterer on the fateful day, some of the teachers were vomiting and afflicted by diarrhoea, as a result of which they were rushed to the Federal Medical Center, Katsina and the Police Clinic for medication.Ten of the affected teachers were said to have died as a result of the infection.State police spokesperson Abubakar Ibrahim confirmed the incident to reporters.He said only one teacher died, while 19 others were hospitalized.He said 12 of the affected teachers had already been discharged from the hospitals, while seven others were still on admission at the Federal Medical Center and Katsina Police Clinic.He said the police had already collected sample of the food supplied by the caterer for clinical analysis.